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Adult stem cells are a promising cell source for cartilage regeneration. They resided in a special microenvironment known as the
stem-cell niche, characterized by the presence of low oxygen concentration. Cobalt chloride (CoCl2) imitates hypoxia in vitro by
stabilizing hypoxia-inducible factor-alpha (HIF-1α), which is the master regulator in the cellular adaptive response to hypoxia.
In this study, the influence of CoCl2 on the chondrogenic potential of human MSCs, isolated from dental pulp, umbilical cord,
and adipose tissue, was investigated. Cells were treated with concentrations of CoCl2 ranging from 50 to 400 μM. Cell viability,
HIF-1α protein synthesis, and the expression of the chondrogenic markers were analyzed. The results showed that the CoCl2
supplementation had no effect on cell viability, while the upregulation of chondrogenic markers such as SOX9, COL2A1,
VCAN, and ACAN was dependent on the cellular source. This study shows that hypoxia, induced by CoCl2 treatment, can
differently influence the behavior of MSCs, isolated from different sources, in their chondrogenic potential. These findings
should be taken into consideration in the treatment of cartilage repair and regeneration based on stem cell therapies.
1. Introduction
Hyaline articular cartilage has a very limited or no intrinsic
capacity for repair and minor traumatic lesions or patholog-
ical injuries may trigger progressive damage and joint degen-
eration [1]. Early intervention is needed to avoid growth of
traumatic chondral and osteochondral defects and to delay
cartilage degeneration and osteoarthritis.
Novel cell-based tissue engineering techniques have
been proposed with the aim to repair cartilage defects
and reconstitute the properties of hyaline cartilage. The
mesenchymal stromal cells (MSCs), due to the high prolif-
erative capacity, self-renewal, and potential to differentiate
into different lineages, represent a promising strategy in
regenerative medicine [2]. The MSCs are separated from
several human tissues such as the bone marrow [3], the
synovial tissue [4], the adipose tissue [5, 6], the periosteum
[7, 8], the dental pulp [9] and Wharton’s jelly umbilical
cord [10].
The microenvironment of MSCs is characterized by a low
oxygen tension, demonstrating that MSCs might be quite
resistant to oxygen limitation [11]. Changes in the oxygen
concentration activate intracellular mechanisms responsible
either for cell death or for cell adaptation to new environ-
mental conditions [11, 12]. The key adaptive response to
hypoxic conditions is the stabilization of hypoxia-inducible
factor- (HIF) 1 [13]. As a transcription factor, it plays a vital
role in the functional expression of a number of genes
involved in the adaptation and survival of cells, tissues, and
organs. The transcription factor HIF-1 is composed of two
subunits, HIF-1α and HIF-β or aryl hydrocarbon receptor
nuclear translocator (ARNT) [14]. In both normoxic and
hypoxic conditions, the HIF-β is constantly biosynthesised,
degraded, and recycled [15]. HIF-1α in normal oxygen
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condition, despite being biosynthesised, is subjected to the
instantaneous decomposition [16]. In normoxic conditions,
HIF-1α is polyhydroxylated by oxygen-dependent prolyl
(P4HS) and arginyl hydroxylases (FIH). Once hydroxylated,
HIF-1α protein binds to von Hippel–Lindau (VHL) tumor
suppressor protein—the recognition component of E3
ubiquitin-protein ligases—and is rapidly degraded by the
proteasome. In hypoxic condition, hydroxylation is inhib-
ited, which leads to the stabilization of HIF-1α and its
accumulation in the nucleus [14, 17]. All P4Hs are 2-
oxoglutarate dioxygenases and require Fe2+, 2-oxoglutarate,
O2, and ascorbate. Thus, even small decreases in the O2
concentration will inhibit the activities of the HIF-P4Hs
so that HIF-1α escape degradation [17].
Recent evidences suggested that hypoxia is involved in the
chondrogenic differentiation of MSCs [18]. Expansion and
chondrogenic induction of the bone marrow-derived MSCs
under hypoxia generally result in enhanced chondrogenic dif-
ferentiation, while they showed a reduced capacity in differ-
entiating into adipogenic and osteogenic lineage [19–21].
In in vitro studies, hypoxia is generally induced by
decreasing atmospheric oxygen concentrations or by utiliza-
tion of mimetic chemical agents such as cobalt chloride
(CoCl2) and desferrioxamine (DFO). Chemical agents are
more attractive in experimental laboratories because they
are cheap, they maintain steady oxygen tension, and they
are more stable compared to hypoxic chamber. They artifi-
cially induce hypoxia through blocking the degradation of
HIF-1α [22]. Cobalt chloride has been reported to inhibit
the activities of HIF-P4Hs and FIH, suggesting that it may
occupy their Fe2+ binding site and block the degradation of
HIF-1α [17]. It is demonstrated that the effects of hypoxia-
mimetic agents are comparable to those resulting from
reduced atmospheric oxygen levels [17].
Despite several studies on the impact of hypoxia precon-
ditioning onMSC differentiation, the influence of hypoxia on
MSC behavior is still a matter of discussion. The data on their
response to hypoxic conditions are rather controversial,
demonstrating both damaging and ameliorating effects. The
present study was aimed to compare the effects of hypoxia,
induced by CoCl2, among the human MSCs derived from
human dental pulp, adipose tissue, and Wharton’s jelly
umbilical cord, and their response to chondrogenic induction
under hypoxic conditions.
2. Materials and Methods
2.1. Mesenchymal Stem Cells. The human adipose mesenchy-
mal stem cells (ADMSCs) were purchased from Invitrogen
(Life Technologies, Monza, Italy). The human dental pulp
mesenchymal stem cells (DPMSCs) were obtained from
healthy permanent premolars extracted during orthodontic
treatment, under informed consent [9]. The human umbili-
cal cord mesenchymal stem cells (UBMSCs) were obtained
from the tissue of umbilical cords of full-term pregnancies.
Informed consent was obtained from each patient according
to the guidelines of the National Bioethics Committee, and
the samples were treated following a protocol approved
by the University of Bologna. All the cells were maintained
at 37°C and 5% CO2 in DMEM/F12 Glutamax® medium
(Gibco, Thermo Fisher, Monza, Italy) supplemented with
10% FBS (v/v) and 1% (v/v) penicillin and streptomycin
(Gibco, Thermo Fisher, Monza, Italy). In this study, all the
cells were used between passages 4 and 7.
2.2. Immunophenotyping. The DPMSCs, UCMSCs, and
ADMSCs were checked for their surface marker profile by
FACSCalibur flow cytometry system (Becton Dickinson,
CA, USA) as already described [8, 9, 23]. Briefly, the MSCs
were detached from the surface of the flask with enzyme
digestion for 3 minutes at room temperature, collected, and
centrifuged at 300g for 5 minutes. The pellets were resus-
pended in stain buffer and the cells were counted by hemocy-
tometer. Then, 2.5× 105 cells were incubated for 45min, in
the dark at 4°C, with the following antibodies: fluorescein iso-
thiocyanate- (FITC-) labeled mouse antihuman CD90 (Stem-
Cell Technologies, Milan, Italy), CD105, CD14, and CD19
(Diaclone, France); R-phycoerythrin- (PE-) labeled mouse
antihuman CD34, CD44, CD45 (Diaclone, France), and
CD73 (Becton Dickinson, CA, USA); and anti-HLA-DR
(Diaclone, France). The control for FITC- or PE-coupled
antibodies was isotypic mouse IgG1. The data were evaluated
using CellQuest software (Becton Dickinson, CA, USA).
2.3. Cobalt Chloride Treatment and MTT Assay. The cells
were seeded in 96-well culture plates at a density of 1× 104
cells/well for 24 h. The culture medium was changed to fresh
MEM containing 2% FBS and 1% antibiotics and treated with
different concentrations of CoCl2 ranging from 50 to 400μM.
After 24h and 48h, the medium was changed with a new one
supplemented with 0.5mg/mL of 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) for 3 h at 37°C.
The formazan produced was dissolved by solvent solution
(0.1N HCl in isopropanol), and the optical density was read
at 570 nm by microplate reader (Model 680, Bio-Rad Lab
Inc., CA, USA).
2.4. HIF-1α Protein Expression. The MSCs were treated with
100μM CoCl2 for 6 h, 12 h, 24 h, and 48 h, and cytosolic
extract was obtained by using RIPA lysis buffer (Pierce,
Thermo Fisher Scientific, Monza, Italy) supplemented with
25μmol/L protease inhibitor cocktail (Pierce, Thermo Fisher
Scientific, Monza, Italy) and 1μL of β-mercapto-ethanol
(Sigma-Aldrich, St. Louis, Missouri, USA). Total proteins
were resolved on 4–12% SDS polyacrylamide gel electropho-
resis (SDS–PAGE) and electrophoretically transferred into a
nitrocellulose membrane using a wet blotting apparatus
(Invitrogen, Thermo Fisher Scientific, Monza, Italy). The
membranes were blocked with dry milk (Invitrogen, Thermo
Fisher Scientific, Monza, Italy) for 30 minutes at room
temperature and were then incubated with antihuman
HIF-1α, diluted 1 : 400 (Invitrogen, Thermo Fisher Scien-
tific, Monza, Italy), and antihuman actin, diluted 1 : 1000
(Cell Signaling Technology, Leiden, The Netherlands) at
4°C over night. After washing with transfer buffer (TBS-T),
each blot was incubated with antirabbit secondary antibody
(1 : 5,000 dilution; Cell Signaling Technology, Leiden, The
Netherlands) for 1 h and 30 minutes at room temperature.
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The antibody signal was visualized with the enhancement
chemiluminescence system (Pierce, Thermo Fisher Scientific,
Monza, Italy). Images were obtained by using Image Station
2000R (Kodak, NY, USA).
Band densitometry was measured using ImageJ software
(National Institutes of Health), and the intensities of the spe-
cific protein bands were corrected for equal actin loading;
they were expressed as relative to the intensity of the control
sample. Data showed the average of triplicates± SD and were
representative from three independent experiments.
2.5. Chondrogenic Differentiation. The MSCs, in micromass
culture, were stimulated with MEM supplemented with 2%
FBS and 100μM CoCl2 for 48 h and then were cultured in
chondrogenic medium consisting in MEM supplemented
with 2% FBS, 10ng/mL of TGF-β3 (Millipore, Milan, Italy),
100 nm dexamethasone (Sigma-Aldrich, St. Louis, Missouri,
USA), 100μg/mL ascorbate-2-phosphate (Sigma-Aldrich,
St. Louis, Missouri, USA), ITS (6.25μg/mL insulin, 6.25μg/
mL transferrin, 6.25μg/mL selenous acid) (Gibco, Thermo
Fisher Scientific, Monza, Italy) for 7, 14, 21, and 28 days.
The chondrogenic medium was replaced every 3 days.
Control samples consisted in MSCs cultured in micromass
system in MEM supplemented with 10% FBS up to 28 days.
At the end of each treatment, the cells were collected and
RNA extraction and quantitative real time PCR (qRT-PCR)
was performed.
2.6. mRNA Extraction and qRT-PCR. RNeasy Mini Kit
(Invitrogen, Thermo Fisher Scientific, Monza, Italy) was
used for the extraction of RNA from cellular pellets, and
200ng of total RNA was reverse transcribed into first-
strand cDNA using SuperScript™ III One-Step RT-PCR Sys-
tem (Invitrogen, Thermo Fisher Scientific, Monza, Italy).
Chondrogenic mRNA marker expression levels were ana-
lyzed via real-time PCR by 7500 real-time PCR machine
(Applied Biosystems, Life Technologies, Monza, Italy).
For mRNA quantification, TaqMan assays (Life Technolo-
gies, Thermo Fischer Scientific, Monza Italy) were used
specific for collagen type II (COL2A1; Hs00264051_m1),
collagen type 10 (COL10A1; Hs00166657_m1), Sox9 (SOX9;
Hs01001343_g1), versican (VCAN; Hs00171642_m1), and
aggrecan (ACAN; Hs00153936_m1). Relative gene expres-
sion levels were normalized to that of glyceraldehyde 3-
phosphate dehydrogenase (GAPDH; Hs99999905_m1). Data
are presented as fold changes relative to levels in control
samples by using formula 2−ΔΔCT, as recommended by
the manufacturer (User Bulletin number 2 P/N 4303859;
Applied Biosystems).
2.7. Alcian Blue and Safranin O Staining. The MSCs were
stimulated with MEM supplemented with 2% FBS and
100μM CoCl2 for 48 h in micromass culture, and then they
were cultured in chondrogenic medium as previously
described. At the end of each experimental point, the MSCs
were immediately fixed in 4% formaldehyde (Sigma-Aldrich,
St. Louis, Missouri, USA) in phosphate buffer (PBS) for 24 h
at 4°C. Then, they were dehydrated in a graded series of eth-
anol and embedded in paraffin wax (Fluka, Sigma-Aldrich).
Paraffin sections of 6μm were obtained with an automated
rotary microtome (Leica Microsystems Srl, Cambridge,
United Kingdom) and collected on Superfrost glass slides
(Carl Roth, Karlshure, Germany). Samples were subsequently
processed for alcian blue staining by using alcian blue and saf-
ranin O staining kits (Bio-Optica, Milan, Italy). Images uti-
lized are representative from three independent experiments.
2.8. Statistical Analysis.MTT and real-time PCR values were
presented as the mean± standard deviation, and each type of
experiment was replicated three times. One way ANOVA
followed by Dunnett’s multiple comparison test was used
to evaluate the differences between the samples. Statistical
analysis was performed by GraphPad Prism 5.0 software
(GraphPad Software Inc., San Diego, CA, USA). P values
of <0.05 were considered statistically significant.
3. Results
3.1. Immunophenotyping. The MSCs utilized for all the
experiments were characterized for CD105, CD14, CD19,
CD34, CD45, CD73, CD90, and HLADR using flow cytomet-
ric analysis. It was found that these cells were highly positive
for CD105, CD73, and CD90 (>95%) and negative for CD34,
CD19, CD45, CD14, and HLA-DR (<3%) (data not showed)
[8, 9, 23]. Moreover, they were able to differentiate into all the
mesenchymal lineages (data not showed) [8, 9, 23].
3.2. MTT Assay. To evaluate the potential toxicity of CoCl2
on MSCs cells, an MTT assay testing different concentration
of CoCl2, ranging from 50μΜ to 400μM, was carried out, for
24 h and 48 h. Results showed a high cell viability in all the
three MSCs tested for 24 h and 48h (Figures 1(a) and 1(b)).
A light reduction of viability was observed after 48 h with
the concentration of 400μM (Figure 1(b)). The concentra-
tion of 100μM showed the highest cell viability both at 24h
and 48 h; therefore, this concentration was used for all the
following experiments.
3.3. HIF-1α Expression. To determine if the treatment with
CoCl2 was responsible of an upregulation of the transcription
factor HIF1α, the expression of the protein after 6 h, 12 h,
24 h, and 48 h of CoCl2 exposition was evaluated by western
blotting analysis (Figure 2).
Apparently, no difference between control and treated
samples was observed by western blot, in the entire MSCs
tested (Figures 2(a)–2(c)). Densitometric analysis of protein
bands showed a time-dependent upregulation of HIF-1α in
DPMSCs and UCMSCs, while no significant difference was
evaluated in ADMSCs (Figure 2(d)). After 48 h of CoCl2
incubation, the expression of HIF-1α was increased at about
4.4-fold in DPMSCs and UCMSCs (Figure 2(d)) compared to
that in each control sample.
3.4. Chondrogenic Differentiation of DPMSCs, UCMSCs, and
ADMSCs in Hypoxia. To determine if hypoxia, induced by
CoCl2, enhances chondrogenic differentiation, DPMSCs,
UCMSCs, and ADMSCs were preincubated with 100μM
CoCl2 for 48 h, and then they were induced to chondrogenic
differentiation by chondrogenic medium up to 28 days. At
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each experimental point, the gene expression of the chon-
drogenic markers SRY-box containing gene 9 (SOX9), a
key transcription factor for chondrocyte differentiation,
type II collagen (COL2A1), versican (VCAN), and aggre-
can (ACAN), downstream targets of SOX9, was assessed
by qRT-PCR (Figure 3).
The DPMSCs showed an upregulation of about 3-fold of
the transcription factor SOX9 after 7 days of chondrogenic
differentiation, followed by a reduction of expression after
14, 21, and 28 days of induction (Figure 3(a)). An upregula-
tion of VCAN was also observed after 7, 14, 21, and 28 days
of chondrogenic stimulation (Figure 3(a)), while no amplifi-
cation was detected for mRNA corresponding to COL2A1
and ACAN (Figure 3(a)).
The UCMSCs showed a time-dependent upregulation of
all the chondrogenic markers tested (Figure 3(b)). The SOX9
mRNA level reached the highest level after 21 days of differ-
entiation, while COL2A1 mRNA expression was observed
after 14 days of differentiation and increased about 5-fold
after 28 days (Figure 3(b)). VCAN mRNA showed a light
time-dependent upregulation, while the expression of ACAN
mRNA was significantly increased up to 21 and 28 days of
chondrogenic differentiation (Figure 3(b)).
On the contrary, the ADMSCs showed a constant expres-
sion of SOX9 and ACAN compared to control samples
(Figure 3(c)), while an upregulation of expression was
detected for COL2A1 and ACAN mRNA at the end of the
chondrogenic induction (Figure 3(c)).
To demonstrate the absence of hypertrophic chondro-
genesis, a qRT-PCR to evaluate the expression of the hyper-
trophic chondrogenic marker, collagen type 10, was carried
out. Results showed a low signal of collagen type 10 in the
UCMSCs and DPMSCs after 28 days of differentiation
(Figure 4), while the ADMSCs showed a light but statistically
significant upregulation of collagen type 10 compared to the
control samples (Figure 4).
3.5. Alcian Blue and Safranin O Staining. To demonstrate
the presence of proteoglycans in the extracellular matrix
produced by the MSCs stimulated to chondrogenic differen-
tiation up to 28 days, alcian blue and safranin O stainings
were carried out. Alcian blue results showed an intense blue
color on extracellular matrix produced by the UCMSCs and
ADMSCs (Figure 5), while a very light signal was detected in
the DPMSCs. These data are supported by safranin O stain-
ing, which demonstrated a clear red color, corresponding to
proteoglycan deposition, in the UCMSCs and ADMSCs,
while no red signal was detected in the DPMSCs (Figure 5).
4. Discussion
Articular cartilage damage caused by sports injuries, acciden-
tal trauma, and aging generally progresses to more serious
joint disorders, including osteoarthritis (OA), necrosis of
subchondral bone, or arthritis [1, 2]. The hyaline articular
cartilage has a very limited or no intrinsic capacity for repair,
and even minor lesions or injuries may trigger progressive
damage and joint degeneration [1]. Current treatments,
based on surgical interventions, are still not satisfactory,
often followed by the development of fibrocartilage [2]. Now-
adays, repair and regeneration of hyaline cartilage are still a
challenge. Novel cell-based tissue engineering techniques
have been proposed with the aim to repair defects with
bioengineered tissue that mimics the properties of hyaline
cartilage and helps in the integration into native tissue.
Transplantation of MSCs is a promising strategy based on
their high proliferative capacity, self-renewal, and potential
to differentiate into cartilage-producing cells. However, still
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Figure 1: Effects of different concentration of CoCl2 on the DPMSCs, UCMSCs, and ADMSCs. (a) Cells treated for 24 h; (b) cells treated for
48 h. Cell viability was determined by MTT assay and the results were expressed as relative cell viability compared to each control sample.
Each value is the mean± SD of triplicate independent experiments. ∗p < 0 05, as compared to control DPMSCs; #p < 0 05, as compared to
control UCMSCs; §p < 0 05, as compared to control ADMSCs.
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biological obstacles persist in the MSC-based regeneration of
articular cartilage [1]. Mechanical properties of the recon-
structed cartilage are inferior to the native tissue, and hetero-
geneity of initial cell population and poor matrix deposition
contribute to functional limitation of the MSCs [1].
Increasing evidence indicates that environmental pre-
conditioning is a powerful approach in promoting stem cell
proliferation and chondrogenic potential [24]. In the native
cartilage, cells are exposed to very low oxygen tension which
promotes MSC survival, proliferation, and differentiation
capacity [24]. However, the data regarding the effect of hyp-
oxia on MSC behavior are still contradictory and the role of
hypoxia is still unclear.
The aim of this study was to compare the behavior of
three human MSCs, separated from dental pulp, Wharton’s
jelly umbilical cord, and adipose tissues, induced to chondro-
genic phenotype under hypoxic environment.
The choice of DPMSCs, UCMSCs, and ADMSCs for
this study reflects their readily accessible source, easy pro-
tocols for isolation, and easy availability without ethical
concerns. They represent the ideal source for stem cell-
based therapy and regenerative medicine. Although the
DPMSCs, UCMSCs, and ADMSCs seem very similar, they
show specific characteristic of the tissue of origin which
diversifies their response to hypoxia and tissue regeneration.
Cobalt chloride, a chemical hypoxia-mimetic agent, is
an attractive alternative to creating physical hypoxic agents
[25–27]. The potential toxicity of CoCl2 on the different
MSCs utilized in this study was investigated by MTT anal-
ysis. The highest cell viability was obtained at 100μM of
CoCl2, after 24 h and 48h in all the three MSCs tested.
Therefore, 100μM was the concentration of cobalt chloride
utilized in the study, in agreement with previous investiga-
tions on murine stem cells [21]. A pretreatment of 100μM
CoCl2 was performed on DPMSCs, UCMSCs, and ADMSCs
for 48 h, as a hypoxic preconditioning approach, with the
aim to promote chondrogenic differentiation [24]. The
mechanism by which hypoxia exerts its effect on cells is
mainly regulated by HIF-1α, which upregulates several
genes involved in glucose metabolism, erythropoiesis, iron
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Figure 2: Effect of CoCl2 in the expression of HIF-1α. TheMSCs were incubated with 100 μMof CoCl2 in cell medium supplemented with 2%
of FCS for 6 h, 12 h, 24 h, and 48 h. (a) HIF-1α expression in the DPMSCs; (b) HIF-1α expression in the UCMSCs; (c) HIF-1α expression in
the ADMSCs; (d) densitometric analysis of western blot bands. Control samples consist in theMSCs cultured with cell medium supplemented
with 10% FCS for 48 h. The value was normalized to each corresponding β-actin level and represented as a relative expression compared to the
control sample. Each value is the mean± SD of triplicate independent experiments. ∗p < 0 05, as compared to control DPMSCs; #p < 0 05, as
compared to control UCMSCs; §p < 0 05, as compared to control ADMSCs.
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transport, angiogenesis, and chondrogenesis [11, 13, 24].
To confirm the hypoxic condition induced by CoCl2, the
presence of HIF-1α protein was evaluated. Results showed
a time-dependent upregulation of HIF-1α, in the DPMSCs
and UCMSCs, compared to untreated control, while no
increase of expression of HIF-1α was detected in the
ADMSCs, compared to control sample. Therefore, CoCl2
successfully mimicked the hypoxic condition in DPMSCs
and UCMSCs but failed in inducing hypoxic microenviro-
ment in ADMSCs. Our data are in agreement with previ-
ous results on murine bone marrow mesenchymal stem
cells [21], human periodontal ligament MSCs [26], and
DPMSCs [25] where the hypoxic induction by CoCl2 trig-
gered the HIF-1α pathway.
The influence of hypoxia, induced by CoCl2, was sub-
sequently investigated on the chondrogenic potential of
DPMSCs, UCMSCs, and ADMSCs. The cell previously
treated with CoCl2 for 48h and then induced to chondro-
genic differentiation up to 28 days showed different results
regarding the mRNA expression of the chondrogenic
markers analyzed. In the DPMSCs, while the transcription
factor SOX9 and VCAN had an increase of expression, there
was no expression of COL2A1 and ACAN. These findings
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Figure 3: Effects of CoCl2 on the MSCs induced to chondrogenic phenotype for 7, 14, 21, and 28 days. mRNA expression of SOX9, COL2A1,
VCAN, and ACAN in (a) DPMSCs, (b) UCMSCs, and (c) ADMSCs. Gene expression was normalized to the corresponding GAPDH and
calculated as relative expression compared to control cells for the DPMSCs and UCMSCs and to D14 for the ADMSCs. The experiments
were performed three times. Data were expressed as mean± SD. ∗p < 0 05, as compared to control SOX9 mRNA; #p < 0 05, as compared
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Figure 4: mRNA expression of COL10A in the ADMSCs,
UCMSCs, and DPMSCs induced to chondrogenic differentiation
up to 28 days. The experiments were performed three times. Data
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ADMSCs; §p < 0 05, as compared to control DPMSCs. #p < 0 05,
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suggest an inhibitory effect of hypoxia, on chondrogenic
differentiation, in agreement with previous data on human
periodontal ligament MSCs and human DPMSCs in which
hypoxia induced by CoCl2 exposition inhibited osteogenic
differentiation and enhanced the upregulation of the stem
cell markers REX1 and OCT4, responsible for maintaining
stemness [26].
Similar results were obtained in the ADMSCs, in which
hypoxia induced by CoCl2 treatment induced a weak chon-
drogenic induction, as expected due to the lack of upregula-
tion of HIF-1α protein observed by western blot. Few
studies investigated the impact of hypoxia on differentiation
of the ADMSCs yielded inconsistent and contrasting results
[28]. It was found that oxygen tension at 2–5% significantly
affected the differentiation capacity of ADMSCs, while oxy-
gen tension at 1 and 1.5%maintained adipogenic, osteogenic,
and chondrogenic differentiation [29]. Fotia and colleagues
[29] reported that hypoxia enhances ADMSC proliferation
and maintains the multipotency status, allowing the differen-
tiation in specific lineages in the presence of proper factors.
However, they demonstrated chondrogenic differentiation
by alcian blue staining without any quantitative data on the
mRNA expression of the chondrogenic markers. Other stud-
ies have demonstrated that low oxygen tension increased the
ADMSC stemness marker expression and proliferation rate
without altering their morphology and surface markers
[30, 31]. Low oxygen tension further enhances the chon-
drogenic differentiation ability but reduces both adipogenic
and osteogenic differentiation potential [32–34]. On the
contrary, Pilgaard and colleagues [34] demonstrated that
hypoxic pretreatment did not exhibit an enhanced chon-
drogenic differentiation in human ADMSCs, in agreement
with our results. We hypothesize that higher concentration
of CoCl2 or a longer duration of CoCl2 supplementation
might be required to induce hypoxic effect on ADMSCs.
In our study, the UCMSCs demonstrated the best
chondrogenic phenotype after a hypoxic pretreatment
and chondrogenic induction up to 28 days. All the chon-
drogenic markers showed an upregulation of their expres-
sion compared to untreated control samples, supported by
alcian blue and safranin O stainings, and a high expression of
the transcription factor HIF-1α, responsible for the upregula-
tion of the downstream chondrogenic genes. Previous studies
demonstrated that chemical hypoxia, induced by 100μM
CoCl2, induced proliferation and mitochondrial protection
and did not alter the differentiation capacity of the human
UCMSCs [35]. Reppel and colleagues [36] reported an
increase in chondrogenic differentiation when Wharton’s
jelly-derived human MSCs were expanded under hypoxia,
in agreement with our results.
5. Conclusion
Our data demonstrated that the effect of hypoxia on chon-
drogenic differentiation of MSCs was dependent on cell
source. The UCMSCs are more prone to chondrogenic differ-
entiation and to nonhypertrophic chondrogenesis, compared
to the DPMSCs and ADMSCs, and these features could be
correlated to the nature of the donor tissue and the different
hypoxic environment of the umbilical cord compared to the
DPMSCs
UCMSCs
ADMSCs
Alcian blue
CTR D28 CTR D28
Safranin O
Figure 5: Alcian blue and safranin O staining on MSC micromasses, previously treated with 100μM CoCl2 and subsequently stimulated to
chondrogenic differentiation up to 28 days. The images are representative of three different experiments (magnification 400x; bar: 100μM).
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adipose tissue and dental pulp [37–39]. These findings
should be taken in great consideration in the choice of stem
cells for prospective regenerative strategies.
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